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Endothelial dysfunction due to vascular inﬂammation and oxidative stress critically contributes to the
etiology of atherosclerosis. The intracellular redox environment plays a key role in regulating endothelial
cell function and is intimately linked to cellular thiol status, including and foremost glutathione (GSH). In
the present study we investigated whether and how the dietary ﬂavonoid, quercetin, affects GSH status
of human aortic endothelial cells (HAEC) and their response to oxidative stress. We found that treating
cells with buthionine sulfoximine to deplete cellular GSH levels signiﬁcantly reduced the capacity of
quercetin to inhibit lipopolysaccharide (LPS)-induced oxidant production. Furthermore, incubation of
HAEC with quercetin caused a transient decrease and then full recovery of cellular GSH concentrations.
The initial decline in GSH was not accompanied by a corresponding increase in glutathione disulﬁde
(GSSG). To the contrary, GSSG levels, which were less than 0.5% of GSH levels at baseline (0.2670.01 vs.
64.771.9 nmol/mg protein, respectively), decreased by about 25% during incubation with quercetin. As a
result, the GSH: GSSG ratio increased by about 70%, from 25377 to 372723. These quercetin-induced
changes in GSH and GSSG levels were not affected by treating HAEC with 500 mM ascorbic acid phos-
phate for 24 h to increase intracellular ascorbate levels. Incubation of HAEC with quercetin also led to the
appearance of extracellular quercetin-glutathione conjugates, which was paralleled by upregulation of
the multidrug resistance protein 1 (MRP1). Furthermore, quercetin slightly but signiﬁcantly increased
mRNA and protein levels of glutamate-cysteine ligase (GCL) catalytic and modiﬁer subunits. Taken to-
gether, our results suggest that quercetin causes loss of GSH in HAEC, not because of oxidation but due to
formation and cellular export of quercetin-glutathione conjugates. Induction by quercetin of GCL sub-
sequently restores GSH levels, thereby suppressing LPS-induced oxidant production.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Activation of the vascular endothelium leading to increased
cellular adhesion molecule expression and monocyte recruitment
to the arterial wall are critical initializing steps in the developmentB.V. This is an open access article u
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.of atherosclerosis. Reactive oxygen species (ROS) have been shown
to be involved in induction of endothelial dysfunction and vascular
inﬂammation in various animal models of human atherosclerosis
[10,24,25]. ROS induce endothelial injury [32], mediate obesity-
related endothelial dysfunction [13,26], and are involved in en-
dothelial activation and adhesion molecule expression upon ex-
posure of endothelial cells to lipopolysaccharide (LPS) or angio-
tensin II [25,27]. ROS also exert pro-atherogenic effects by de-
pleting NO and limiting its protective effects [12].
Glutathione (GSH) is an important intracellular, small-molecule
antioxidant and detoxifying agent. Its relatively high concentration
in cells [29] makes GSH the main intracellular redox buffer to
protect cells from oxidants originating intra- and extracellularly.
As an oxidative stress-related disease, atherosclerosis is sub-
stantially affected by glutathione status. For example, in-
traperitoneal injection of GSH to apolipoprotein E-deﬁcient micender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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and reduced the size of atherosclerotic plaques [33]. Deﬁciency in
the modiﬁer subunit (GCLM) of glutamate-cysteine ligase (GCL)
increased the rate of aortic lesion development in apolipoprotein
E-deﬁcient mice, which was reduced by overexpression of the
catalytic subunit of GCL (GCLC) [6].
GCL catalyzes the synthesis of γ-glutamylcysteine from gluta-
mate and cysteine, which is the rate-limiting step in the de novo
synthesis of GSH. The GCLC subunit binds glutamate and cysteine
and catalyzes their ligation, while GCLM regulates the binding
afﬁnity of GCLC to its substrates [35]. Inhibition of GCL activity by
buthionine sulfoximine (BSO) or nitric oxide (NO) results in cel-
lular GSH depletion [7,19,31]. On the other hand, induction of GCL
is associated with an increase in GSH levels [1,6].
We previously described the antioxidant and anti-in-
ﬂammatory effects of the dietary ﬂavonoid, quercetin (3,3′,4′,5,7-
pentahydroxyﬂavone), in human aortic endothelial cells (HAEC),
but whether GSH plays a role in these effects of quercetin is un-
known. Reports on intracellular GSH concentrations in HAEC are
limited, as are studies on the effects of quercetin on GSH levels in
endothelial cells.
Therefore, in the present study, we hypothesized that cellular
GSH plays a critical role in mediating the antioxidant effects of
quercetin in endothelial cells, and investigated the effects of in-
cubating HAEC with quercetin on GSH oxidation, conjugation, and
cellular export, as well as the induction of GCL.2. Materials and methods
2.1. Materials
Quercetin, GSH and GSSG, tyrosinase (EC 1.14.18.1) (from
mushroom), lipopolysaccharide (LPS), and 2′,7′-dichloroﬂuorescin
diacetate (DCFH-DA) were purchased from Sigma-Aldrich (St.
Louis, MO). All the other chemicals were of the highest grade
available from Sigma-Aldrich.
2.2. Synthesis of quercetin-glutathione conjugates
Quercetin-glutathione conjugates were prepared according to
methods reported by Awad et al. [2]. GSH was dissolved in phos-
phate-buffered saline pH 7.6 (ﬁnal concentration, 1 mM). 100 U/ml
tyrosinase and 150 mM quercetin (100 mM stock solution in
DMSO) were added and the solution was incubated at 37 °C for
8 min and then freeze-dried and extracted with a mixture of 1:1:1
ethanol, methanol and water. Following centrifugation of the so-
lution at 12,000g for 5 min, the supernatant was analyzed by li-
quid chromatography-mass spectrometry (LC-MS).
To purify the quercetin-glutathione conjugates, the solution
was loaded onto an Alltech high-capacity C18 reversed-phase ex-
tract-clean column (Grace, Columbia, Maryland, USA). The column
was then washed with 200 ml water. The quercetin-glutathione
conjugates were eluted with 80 ml 10% (v/v) acetonitrile in water.
Purity of quercetin-glutathione conjugates in 10% (v/v) acetonitrile
was conﬁrmed by HPLC with a Dionex AD20 absorbance detector.
The acetonitrile solution containing the conjugates was then
freeze-dried, weighed, and reconstituted with 1:1:1 ethanol, me-
thanol and water to make a 7 mM standard solution.
2.3. Endothelial cells
Human aortic endothelial cells were obtained from Lonza
(Walkersville, MD). Upon receipt, the cells were seeded in 75-cm2
ﬂasks precoated with 1% (w/v) bovine gelatin (Sigma-Aldrich) at a
ratio of 1:2 and were grown in EBM basal medium (Lonza)containing bovine brain extract, ascorbic acid, hydrocortisone,
epidermal growth factor, 2% (v/v) fetal bovine serum (FBS; Sigma-
Aldrich), and gentamicin/amphotericin-B at 37 °C under 5% CO2 in
a humidiﬁed atmosphere. Medium was replaced periodically until
cells reached 80–90% conﬂuence; cells were then detached with
0.05% (w/v) trypsin-0.02% (w/v) EDTA (Sigma-Aldrich) and sub-
cultured in gelatin-precoated 75 cm2 ﬂasks at a 1:3 ratio. Cells at
passage 7 were used for experiments.
2.4. Experiments
Human aortic endothelial cells at passage 7 were plated in 1%
(w/v) gelatin-precoated 96-well plates or 10-cm dishes with
Medium 199 (Sigma-Aldrich) supplemented with 20% (v/v) FBS
(Sigma-Aldrich), 2 mM glutamine, 50 U/ml penicillin, 50 μg/ml
streptomycin, and 1 ng/ml human basic ﬁbroblast growth factor
(Roche). The cells were then allowed to grow for 3–4 days until
they reached conﬂuence.
Conﬂuent HAEC were incubated without or with different
concentrations (5, 10, or 20 μM) of quercetin for up to 18 h [18].
Quercetin was added from stock solutions freshly prepared in
DMSO and diluted with Medium 199 containing 20% (v/v) FBS. The
ﬁnal concentrations of DMSO in the medium were r0.1% (v/v).
Appropriate controls with the vehicle DMSO were included in all
experiments.
In some experiments, HAEC grown in 10-cm dishes were pre-
incubated without or with 15 mM of the p38 inhibitor, SB203580
(Sigma-Aldrich), for 1 h before the addition of quercetin and in-
cubation for up to 18 h. In other experiments, HAEC were pre-in-
cubated with 500 mM ascorbic acid phosphate for 24 h before
adding quercetin, or cells were co-incubated with 500 mM bu-
thionine sulfoximine (BSO) and 20 μM quercetin for 18 h.
2.5. Real-time quantitative polymerase chain reaction
Total RNA was isolated from HAEC with TRIzol reagent (Life
Technologies, Carlsbad, CA). cDNA was synthesized using a high-
capacity cDNA archive kit (Life technologies). mRNA levels of GCLC
and GCLM were determined by real-time qPCR with an ABI Prism
7500 Sequence Detection System (Life Technologies). Primers and
probes used were purchased from Life Technologies as Assays on
Demand, which contained a 20x mixture of PCR primers and
TaqMan 6-FAM dye-labeled probes. The PCR reactions were set up
with TaqMan Universal PCR Master Mix (Life Technologies). β-
Actin was used as internal control gene. A standard curve of β-
actin and a standard curve of each target gene were constructed to
quantify the level of the target genes relative to the control gene.
2.6. Immunoblotting
Whole cell extracts of HAEC were prepared with a cell extrac-
tion kit (Active Motif, Carlsbad, CA) according to the manufac-
turer's instructions. Equal amounts of protein (20–25 mg) were
separated on 8% or 10% sodium dodecyl sulfate polyacrylamide gel
electrophoresis gels and then transferred to Immobilon poly-
vinylidene diﬂuoride membranes (Millipore, Bedford, MA). The
membranes were blocked in 5% (w/v) nonfat dry milk in phos-
phate-buffered saline containing 0.1% (v/v) Tween 20 for 1 h at
room temperature and then incubated overnight at 4 °C with
speciﬁc primary antibodies to GCLC, GCLM, multidrug resistance
protein 1 (MRP1), or β-actin (Abcam, Eugene, OR) followed by
incubation for 1 h at room temperature with a horseradish per-
oxidase–conjugated secondary antibody (Abcam). The membrane
was then incubated with SuperSignal West Pico Chemilumines-
cent Substrate (Thermo Fisher Scientiﬁc, Eugene, OR) and exposed
to ﬁlms for visualization.
Fig. 1. GSH is involved in the antioxidant effect of quercetin against LPS-in-
duced oxidant production. HAEC were incubated without (Control, LPS) or with
20 μM quercetin (QueþLPS) and 500 μM BSO (QueþBSOþLPS) for 18 h, and then
were washed with HBSS and incubated with 10 μM DCFH-DA for 20 min. After
incubation, DCFH-DA was washed off and medium containing 0.1% (v/v) FBS
without or with 10 μg/ml LPS was added. Fluorescence was measured immediately
after adding LPS and every hour up to 4 h. *Denotes signiﬁcant difference from LPS-
stimulated cells (“10 mg/ml LPS”), Po0.05; #denotes signiﬁcant difference from cells
incubated with quercetin and stimulated with LPS (“20 mM Que þ LPS”), Po0.05.
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Following incubations, HAEC were harvested with trypsin-
EDTA (Sigma-Aldrich), and 1 mM bathophenanthrolinedisulfonic
acid (BPDS)/10% (v/v) perchloric acid was added to the cell sus-
pension. The samples were then centrifuged for 3 min at
15,000 g. The cell pellet was used for total protein measurement.
To 250 ml supernatant, 50 ml 100 mM iodoacetic acid (IAA)/0.2 mM
m-cresol purple and 250 ml KOH (2.0 M)-KHCO3 (2.4 M) were se-
quentially added. After 1 h incubation in the dark at room tem-
perature, 500 ml 1% (v/v) 1-ﬂuoro-2,4-dinitrobenzene was added
and the mixture was incubated in the dark for 1 h at room tem-
perature and then overnight at 4 °C. After incubation, the sample
was centrifuged at 15,000 rpm and the supernatant was used for
HPLC analysis.
HPLC analysis was performed with a Shimadzu liquid chro-
matography system. A Thermo Scientiﬁc APS-2 Hypersil column
(2504.6 mm, 5 mm) was used. The column was eluted at 1.0 ml/
min with mobile 80% phase A (80% (v/v) methanol in water) and
20% mobile phase B (0.5 M sodium acetate in 80% (v/v) methanol)
for 8 min, followed by a linear gradient from 20% mobile phase B
to 99% mobile phase B in 20 min. The percentage of mobile phase
B was kept for 5 min and then a linear gradient from 99% to 20%
mobile phase B in 2 min was used. The percentage of mobile B was
kept at 20% for another 7 min. The injection volume was 80 ml.
Derivatized GSH and GSSG were detected with a Shimadzu SPD-
10Avp detector at 365 nm. For quantiﬁcation, standard curves
were constructed by running GSH and GSSG standards together
with the samples.
2.8. LC-MS analysis of quercetin-glutathione conjugates
Following incubation, HAEC were washed and then extracted
with a mixture of 1:1:1 ethanol, methanol and water. The medium
was freeze-dried and extracted with the same mixture. Samples
were then centrifuged at 12,000g for 5 min. The supernatant was
stored at 80 °C until analysis. To quantify quercetin-glutathione
conjugates, standard was synthesized and puriﬁed as described
above. Sample separation was carried out using a Shimadzu HPLC
system (Columbia, MD) with an Agilent Porshell 120 EC-C8 col-
umn (2.150 mm, 2. 7 mm) coupled with a Sciex API 3000 triple
quadrupole mass spectrometer with a TurboIon Spray source op-
erated with mass analyzer set at unit resolution in negative ion
mode (LC-MS/MS, Sciex API 3000, Foster City, CA). The sample was
separated using a gradient with mobile phase A containing water
with 0.1% (v/v) formic acid and mobile phase B containing acet-
onitrile with 0.1% (v/v) formic acid. The sample was eluted with a
linear gradient from 5% mobile phase B to 10% mobile phase B in
5 min, then a linear gradient from 10% to 12% mobile phase B in
3 min and then a gradient from 12% to 15% mobile phase B in
2 min. The percentage of mobile phase B was kept for 5 min. This
was followed by another linear gradient from 15% to 55% mobile
phase B in 3 min and a gradient from 55% to 90% mobile phase B in
2 min. The percentage of mobile phase B was kept for 1 min and
then a linear gradient from 90% to 5% mobile phase B in 1 min was
used and maintained for 3 min to re-equilibrate the column. The
total elution time was 24.5 min. The ﬂow rate was 0.3 ml/min and
the injection volume was 3 ml. Mass spectrometer source para-
meters were as follows: The Nebulizer, curtain, and collision (CAD)
gas parameters were set at 11, 9, and 5 psi, respectively. Source
temperature was at 400 °C. All gases were high purity nitrogen
supplied by a custom liquid nitrogen system (Polar Cryogenics,
Portland, OR). The ionizing voltage was 4000 V, and the de-
clustering, focusing, entrance, and exit potentials were 50,
220, 10, and 12 V, respectively. A standard curve was con-
structed using puriﬁed quercetin-glutathione conjugate andmultiple reaction monitoring (MRM) to quantify the conjugates in
samples.
2.9. Intracellular oxidant production
Intracellular oxidant production was measured using 2′,7′-di-
chloroﬂuorescein diacetate (DCFH-DA). Following incubations,
HAEC in 96-well plates were washed with HBSS buffer, and then
incubated with 10 mM DCFH-DA for 20 min. After washing the cells
again, they were incubated with 10 mg/ml LPS in medium con-
taining 0.1% (v/v) FBS. Fluorescence was measured immediately
after adding LPS and then every hour up to 4 h using a Spectromax
Gemini XS multiplate ﬂuorometer (Molecular Devices, Sunnyvale,
CA) with excitation and emission settings of 485 nm and 530 nm,
respectively.
2.10. Cell viability
Cell viability was determined with Cell Proliferation Reagent
WST-1 (Sigma-Aldrich) according to the manufacturer's
instructions.
2.11. Statistical analysis
Data are expressed as means 7 SEM of at least three in-
dependent experiments run in triplicate. Data were analyzed by
factorial analysis of variance (ANOVA) or unpaired student's t-test.
Signiﬁcance was accepted at Po0.05.3. Results and discussion
3.1. GSH is involved in the antioxidant effect of quercetin against
LPS-induced oxidant production
To investigate whether GSH is involved in the antioxidant effect
of quercetin, BSO was used to inhibit GCL and deplete intracellular
GSH levels [5,11,34]. HAEC were incubated with 20 mM quercetin
alone or 20 mM quercetin and 500 mM BSO for 18 h, washed to
C. Li et al. / Redox Biology 9 (2016) 220–228 223remove any remaining quercetin, and then stimulated with LPS. As
shown in Fig. 1, intracellular oxidant production, as measured by
DCFH-DA ﬂuorescence, was signiﬁcantly increased by LPS com-
pared to unstimulated control cells. The increase in DCFH ﬂuor-
escence by LPS was completely suppressed by quercetin. However,
in the presence of BSO, the inhibitory effect of quercetin on oxi-
dant production was signiﬁcantly reduced, suggesting that GSH, in
part, mediates the antioxidant effect of quercetin in HAEC.
3.2. Quercetin affects cellular glutathione levels and redox ratio
To investigate the effect of quercetin treatment on intracellular
GSH status, HAEC were incubated with 20 mM quercetin for dif-
ferent time periods, and the concentrations of GSH and GSSG were
determined by HPLC with spectrophotometric detection. We
found that GSH levels decreased by 20%, from 64.771.9 toTime (h)
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Fig. 2. Quercetin affects cellular glutathione levels and redox ratio. HAEC were incu
incubated without (Control, Que) or with 500 μM ascorbic acid phosphate (AAP) for 24 h
(a, d) and GSSG (b, e) levels were determined by HPLC, and the GSH/GSSG ratio for ea
Po0.05 (a, b, c). Results marked with a different letter differ signiﬁcantly, Po0.05 (d, e52.074.0 nmol/mg protein, during the ﬁrst 3 h of incubation with
quercetin; remained constant for the next 3 h; and then gradually
increased to reach initial levels after 18 h of incubation (Fig. 2a).
GSSG levels, which were less than 0.5% of GSH levels at baseline
(0.2670.01 nmol/mg protein), decreased by about 50% during the
ﬁrst 6 h of incubation with quercetin; and then slightly increased
after 12 and 18 h, but remained signiﬁcantly lower than baseline
GSSG levels (Fig. 2b). As a result of the very low cellular GSSG
levels, the GSH: GSSG ratio was very high at baseline (253727),
indicative of a highly reducing intracellular redox environment in
HAEC. The GSH: GSSG ratio further increased during incubation
with quercetin (Fig. 2c); this increase was mainly due to the de-
crease in GSSG, which was most pronounced at 6 h of incubation
(Fig. 2b), coinciding with the highest GSH: GSSG ratio (Fig. 2c). A
higher GSH: GSSG ratio indicates a more negative redox potential
of the GSSG:2GSH couple, which might make the cells moreTime (h)
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in GSH levels.
The ﬁnding that GSSG levels did not increase, but rather de-
creased, upon incubation of HAEC with quercetin suggests that the
observed decrease in GSH levels was not due to oxidation. To
further investigate this notion, HAEC were treated with ascorbic
acid phosphate (AAP) before incubation with quercetin. We and
others have shown previously that HAEC are depleted of ascorbic
acid under standard cell culture conditions but can be enriched
with ascorbate upon incubation with AAP; this, in turn, decreases
background levels of ROS [29] and protects cells against ROS-in-
duced glutathione depletion [14]. Incubation of HAEC with AAP
successfully increased intracellular ascorbate concentrations from
non-detectable levels (o2 pmol/mg protein) to 1.9170.08 nmol/
mg protein, as assessed by HPLC analysis with electrochemical
detection. However, pre-incubation with AAP did not prevent the
loss of GSH and GSSG caused by quercetin treatment, both after
6 and 12 h of incubation (Fig. 2d and e). These results are con-
sistent with the notion that the quercetin-induced loss of GSH
(Fig. 2a) is not due to oxidation, suggesting alternative
mechanisms.Fig. 3. Mass spectra of quercetin-glutathione conjugates. Synthetic quercetin-glutathi
with 20 mM quercetin for 12 h(c) were analyzed by multiple reaction monitoring (MRM)
in negative ion mode (b). The MRM of speciﬁc m/z¼606.10 value representing quercetin
without quercetin for 12 h (d). A standard curve of quercetin-glutathione conjugates w
per second.3.3. Formation of quercetin-glutathione conjugates
Quercetin, like all ﬂavonoids, are metabolized by humans as
xenobiotics, and conjugation to GSH is an important reaction for
cellular detoxiﬁcation and disposal of xenobiotics [20]. Quercetin-
glutathione conjugates have been found in several cell types upon
incubation with quercetin [23,30], but have never been identiﬁed
in endothelial cells. To investigate whether quercetin-glutathione
conjugates are formed in HAEC during quercetin treatment, cells
were incubated with 20 mM quercetin for 12 h. Glutathionyl con-
jugates of quercetin in cell extracts and the culture medium were
identiﬁed by LC-MS, using synthetic quercetin-glutathione con-
jugates as standard.
The [M–H] ion of the quercetin-glutathione conjugates was
detected at m/z 606.10. For the puriﬁed quercetin-glutathione
conjugate standard, a peak appeared with a retention time of
7.93 min in the MRM of m/z 606.10/333.00 (Fig. 3a). According to
the fragmentation patterns of its MS/MS spectrum (Fig. 3b), the
fragment ion (m/z 333.00) ofm/z 606.10 was chosen as the MRM of
glutathionyl quercetin. A corresponding peak in the MRM (m/z
606.10/333.00) of the culture medium of quercetin-treated HAEC
was observed at 7.91 min (Fig. 3c), which presented the same MS/
MS spectrum as the synthesized glutathionyl quercetin standardone standard (a) and reaction product from the culture medium of HAEC incubated
HPLC. The quercetin-glutathione conjugates (m/z 606.10) were identiﬁed by MS/MS
-glutathione conjugates was not detected in cell culture medium of HAEC incubated
as built using puriﬁed synthetic quercetin-glutathione conjugates (e). cps.: counts
C. Li et al. / Redox Biology 9 (2016) 220–228 225(Fig. 3b). Therefore, the existence of the quercetin-glutathione
conjugate in the culture medium of quercetin-treated cells was
conﬁrmed. The speciﬁc position of the glutathionyl group on
quercetin was not determined, but previous reports suggest that
GSH reacts with quercetin at the 6- or 8-position [2,3] (Fig. 3b).
In contrast, the chromatogram representing the quercetin-
glutathione conjugate was not detected in the medium of HAEC
incubated without quercetin (Fig. 3d). Furthermore, no quercetin-
glutathione conjugates were detected in the cell extracts of HAEC
incubated with quercetin; in fresh cell culture medium; or in
culture medium to which quercetin had been added (data not
shown). These data strongly suggest that quercetin-glutathione
conjugates are formed inside HAEC upon incubation with quer-
cetin and rapidly excreted into the extracellular milieu; and hence
are only detectable in the medium, but not in cellular extracts.
To quantify the quercetin-glutathione conjugates released by
HAEC, a standard curve was constructed with puriﬁed standards
(Fig. 3e) and the concentration of conjugates in the medium wasFig. 4. Quercetin induces MRP1 expression. HAEC were incubated for 6 or 18 h witho
measured by immunoblotting (a) and quantitatively analyzed (b). *Denotes signiﬁcant dcalculated. The quercetin-glutathione conjugates were detected in
the medium of quercetin-treated HAEC at an average concentra-
tion of 9.471.1 nM, which corresponds to 0.2170.03 nmol/mg
protein of HAEC. As discussed above, quercetin treatment caused
GSH levels in HAEC to initially drop by 12.7 nmol/mg protein
(Fig. 2a). Therefore, the amount of quercetin-glutathione con-
jugates detected in the medium only accounts for about 1.7% of the
decrease in intracellular GSH levels. However, quercetin-con-
jugates are not stable, with a reported half-life of only minutes in
aqueous solution [4]. It is, therefore, likely that a substantial por-
tion of the quercetin-conjugates was degraded and lost during
incubation and subsequent sample work up. In addition, mea-
surements by us (data not shown) and others [36] have shown
that quercetin itself is not stable in aqueous solution and almost
completely lost after 18 h of incubation in cell culture medium.
This may lead to decreased formation of quercetin-glutathione
conjugates in HAEC upon prolonged incubation, further con-
tributing to the low yield in the extracellular medium.ut (Con) or with 20 mM quercetin (Que). MRP1 protein levels in cell extracts were
ifference from the corresponding Control, Po0.05.
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The multidrug resistance protein 1 (MRP1) is an ATP-binding
cassette transporter on membranes known to be involved in cross-
membrane cellular export of glutathione and glutathione con-
jugates [9,16,21,22]. To investigate whether MRP1 is involved in
the effect of quercetin on cellular glutathione status, HAEC were
incubated with 20 mM quercetin for up to 18 h, and MRP1 protein
expression was determined by immunoblotting. Quercetin in-
duced signiﬁcant increases in MRP1 protein levels at both 6 and
18 h of incubation (Fig. 4). These results suggest that MRP1-
mediated export of quercetin-glutathione conjugates, and possibly
GSH and GSSG, plays a signiﬁcant role in the quercetin-induced
changes in cellular glutathione status of HAEC.
3.5. Quercetin induces GCLC and GCLM expression
GCL catalyzes the formation of γ-glutamylcysteine from cy-
steine and glutamate, which is the rate-limiting step of glu-
tathione synthesis. To investigate whether GCL is involved in
quercetin's effects on cellular glutathione levels, mRNA and pro-
tein levels of GCLC and GCLM in quercetin-treated HAEC were
determined. Incubation for 18 h with quercetin dose-dependently
increased mRNA levels of GLCM. Quercetin at 5 mM and 20 mM
signiﬁcantly increased mRNA levels of GCLC, but no obvious dose-
response was observed (Fig. 5a). Furthermore, incubation of HAEC
with 20 mM quercetin for 6 or 18 h caused a signiﬁcant increase in
GCLM protein levels, while GCLC protein levels were only sig-
niﬁcantly elevated after 18 h of incubation (Fig. 5b–d).Fig. 5. Quercetin induces GCLC and GCLM expression. HAEC were incubated for 18 h w
levels of GCLC and GCLM were measured by real-time qPCR (a). Furthermore, HAEC were
levels of GCLC and GCLM were determined by immunoblotting (b) and quantitatively
Po0.05.3.6. The protein kinase p38 is involved in quercetin-induced GCLC
and GCLM expression
We have previously shown that quercetin induces the anti-
oxidant enzymes, heme oxygenase 1 and NAD(P)H: quinone oxi-
doreductase 1, in HAEC through a mechanism involving activation
of the p38 mitogen-activated protein kinase (p38) and the tran-
scription factor, nuclear factor erythroid 2-related factor 2 (Nrf2)
[17]. To investigate the role of p38 in mediating the upregulation
of GCL by quercetin, HAEC were pre-incubated with 15 mM
SB203580, a speciﬁc p38 inhibitor, for 1 h, and then were in-
cubated for another 12 h with 20 mM quercetin. SB203580 sig-
niﬁcantly inhibited quercetin-induced GCLC and GCLM mRNA ex-
pression (Fig. 6), suggesting that quercetin induces GCLC/GCLM
through p38. These results are consistent with previous reports of
the involvement of p38 in regulating antioxidant enzyme expres-
sion [8,15].
As mentioned above, quercetin almost completely degrades in
cell culture medium within 18 h of incubation. According to our
ﬁndings in the present and previous [17] studies, it takes a certain
time for p38 and Nrf2 to be activated by quercetin and for gene
transcription and protein expression of Nrf2 target proteins (MRP-
1, GCLC and GCLM) to be induced, with maximal protein expres-
sion observed after 18 h of incubation. Quercetin might also ac-
cumulate and be present in cells beyond 18 h of incubation, which
would allow it to continue to exert biological effects despite the
fact that extracellular quercetin has been completely degraded.
However, the concentration and time course of quercetin's in-
tracellular accumulation in HAEC are not known and require fur-
ther investigation.ithout (Control) or with the indicated concentrations of quercetin (Que) and mRNA
incubated for 6 h or 18 h without (Con) or with 20 mM quercetin (Que), and protein
analyzed (c, d). *Denotes signiﬁcant difference from the corresponding Control,
Fig. 6. The protein kinase p38 is involved in quercetin induced GCLC and GCLM
expression. HAEC were incubated for 1 h without (Control) or with 15 mM of the
p38 inhibitor, SB203580 (SB), and then were incubated without or with 20 mM
quercetin (Que) for 12 h. mRNA levels of GCLC and GCLM were measured by real-
time qPCR. Results marked with different letters differ signiﬁcantly, Po0.05.
C. Li et al. / Redox Biology 9 (2016) 220–228 227In summary, the results presented here show that quercetin
signiﬁcantly affects glutathione levels and redox ratio of HAEC.
Quercetin caused a temporary decrease and then full recovery of
intracellular GSH concentrations. The initial drop of GSH levels
was not due oxidation to GSSG, but instead due to formation of
quercetin-glutathione conjugates–demonstrated here for the ﬁrst
time in an endothelial cell type using LC-MS–and the rapid cellular
export of these conjugates via MRP-1. At the same time, quercetin
signiﬁcantly lowered intracellular GSSG levels, likely due to MRP1
mediated export, thus increasing the GSH: GSSG ratio and making
the intracellular redox environment even more reducing. The re-
covery of GSH levels upon prolonged incubation of HAEC with
quercetin was preceded by upregulation of GCL, the rate-limiting
enzyme in the de novo synthesis of GSH, due to quercetin-induced
Nrf2 activation by a pathway involving p38. The induction of GCL
might give HAEC an increased ability to rapidly synthesize GSH
during an oxidant challenge. These quercetin-induced changes in
glutathione levels and redox ratio may explain the antioxidant
effects of quercetin against LPS-induced oxidant production in
endothelial cells.Acknowledgment
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